创新药ETF天弘：8月21日融资净买入50.08万元，连续3日累计净买入454.42万元

Core Insights - The Tianhong Innovation Drug ETF (517380) experienced a net financing purchase of 500.08 thousand yuan on August 21, 2025, with a total financing balance of 1715.06 thousand yuan, indicating a continuous net purchase trend over the past three trading days [1][2]. Financing Activity Summary - On August 21, 2025, the net financing purchase was 50.08 thousand yuan, with a financing balance of 1715.06 thousand yuan, reflecting a 3.01% increase from the previous day [2][3]. - Over the last three trading days, the cumulative net financing purchase reached 454.43 thousand yuan, with 13 out of the last 20 trading days showing net financing purchases [1]. - The financing balance on August 20 was 1664.98 thousand yuan, which had increased by 302.89 thousand yuan, representing a 22.24% rise [3]. Margin Trading Overview - The total margin trading balance on August 21 was 1715.06 thousand yuan, which increased by 50.08 thousand yuan, marking a 3.01% change [3]. - The margin trading balance had previously fluctuated, with a notable increase of 302.89 thousand yuan on August 20, indicating active trading behavior [3].